Noah Flynn

Noah Flynn is a research scientist at Amazon with a PhD in Computational Biology from Washington University in St. Louis. He has developed deep learning applications to screen drugs for bioactivation, reactive metabolite formation, drug-drug interactions, and other types of toxicity problems. He has worked at AbbVie and Merck on analysis of gene regulatory networks and protein-protein interactions and applications of generative models to construct and optimize novel compound libraries. He now researches applications of large language models at Amazon.